MedTrace Logo

Clinic Trial for West China Perioperative Transfusion Score (WCPTS)

NCT01597232 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1351

Last updated 2019-11-20

No results posted yet for this study

Summary

Guidelines for blood transfusion have been issued for years. According to these guidelines, red blood cells (RBCs) transfusion should be given when the hemoglobin level is less than 6g/dL or 7g/dL and is unnecessary when the level is more than 10g/dL. However, in all the guidelines, the determination of whether RBCs should be administered when the hemoglobin level is in the range of 6\~10g/dL is based on the judgment from anesthesiologists or surgeons. Index of transfusion trigger for patients with hemoglobin level between 6g/dL and 10g/dL is necessary and important in clinical practice.

Based on the aim of blood transfusion that maintain the balance of oxygen supply and oxygen consumption, the investigators hypothesize that index of transfusion trigger for patients with hemoglobin level between 6g/dL and 10g/dL could be calculated by parameters including infusion rate of adrenalin for maintaining normal cardiac output, fraction of inspired oxygen, core temperature, and angina. To verify this hypothesis, the investigators present West China Perioperative Transfusion Score (WCPTS) for the trigger of transfusion according to the patient's history and monitoring parameters, and the investigators design a randomized controlled clinical trial to test this score.

Conditions

  • Transfusion Related Complications

Interventions

OTHER

Transfusion trigger based on WCPTS

Determination of whether a patient needs red blood cell transfusion or which hemoglobin level should be maintained is based on WCPTS

OTHER

Maintenance of hemoglobin level more than 10g/dL

The patient's hemoglobin level is maintained more than 10g/dL perioperatively

OTHER

Transfusion trigger based on experience

Determination of whether the patient need red blood cell transfusion or which hemoglobin level should be maintained is based on the physician's experience

Sponsors & Collaborators

  • West China Hospital

    lead OTHER

Principal Investigators

  • Ren Liao, M.D. · Department of Anesthesiology, West China Hospital, Sichuan University

  • Jin Liu, M.D. · Department of Anesthesiology, West China Hospital, Sichuan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-07
Primary Completion
2017-01-20
Completion
2019-02-18

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01597232 on ClinicalTrials.gov